CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

Does treatment of psoriasis with biologics affect the cardiac outcome?. a study in a group of jordanian patients

Author: 
Ramzi Alhyari, Jehad Alassaf, Ashraf Alqubbaj, Ayman Alqaqaa and Salah A. Alabdallat
Subject Area: 
Health Sciences
Abstract: 

Introduction: Psoriasis is one of the major diseases for which patients visit dermatology clinics. Not only it affects the skin, but also its multi-systemic nature is being more recognized. Apart from the well-known psoriatic arthritis, psoriasis has been shown to increase the likelihood of ischemic heart disease, partly due to the stress and lifestyles patients may adopt, and also more importantly and as recently presumed due to the inflammatory nature of the disease. In studies on patients treated with systemic immunomodulators including TNF alpha inhibitors, interleukin-12/23 inhibitors, and interleukin-17 inhibitors, ischemic heart disease showed improvement. Objective: To determine whether or not ischemic heart disease improves with treatment of psoriasis with biological therapy at King Hussein Medical Centre, Jordanian Royal Medical Services. Methods: We aim to assess psoriatic patients who are planned or currently receiving biological treatments for psoriasis at King Hussein Medical Centre for the presence of ischemic heart disease at the cardiology clinics at Queen Alia Heart Institute. We plan to reassess them after clinical psoriasis improvement. Results: All the patients improved more than 50%(according to PASI score) regarding their psoriasis when reevaluated 14 months after starting biologics. About 54% of patients who were found to have non-calcific coronary plaques, showed reduction by 5%-15% in coronary plaque burden after 14 months from starting biologics. Conclusion: Treatment of moderate to severe psoriasis with biological agents has a positive effect in reducing and altering the coronary non-calcific plaque burden.

PDF file: 

Announcement

  • FAST PUBLICATION : AUGUST 2022
  • IMPACT FACTOR: 7.992
  • QUALIS INDEXING
  • HIGH IMPACT FACTOR
  • INTERNATIONAL JOURNAL OF CURRENT RESEARCH

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Dr. Abdul Hannan Abdul Mannan Shaikh
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran